
Welcome to the HERO Lab
Health disparities affect populations across the cancer continuum, from prevention through end-of-life. The goal of our lab is to listen to communities about their cancer-related health needs, act on these findings to create new interventions, and disseminate these interventions to the people who need them most. We work across disciplines, including psychology, medicine, nursing, and pharmacy. We employ multiple community-engaged scientific and experimental modalities including qualitative research, observational studies, and clinical trials.
Current areas of focus include disparities in Immune Checkpoint Inhibitor (ICI) treatment outcomes among Black and White patients, ICI treatment outcomes in patients with advanced cancer, cancer survivorship needs of sexual and gender minority cancer patients and their caregivers, and other cancer-related community engagement projects.

Charles S. Kamen, Ph.D., M.P.H.
Principal Investigator
Projects
- DiRECT: Disparities in Results of Immune Checkpoint Inhibitor Treatment Cohort Study (UG3CA260602)
- FOCUS-SGM: Adapting the FOCUS Program for Sexual and Gender Minority Cancer Patients and Caregivers
- ASCEND: A Multi-Institute Survivorship Study of Patients Living with Advanced and Metastatic Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
- Q Cancer Research Center: Funded by an American Cancer Society Cancer Health Research Center Grant
Publications
View All Publications- Prevalence of Patient-Reported and Clinician-Graded cognitive symptomatic adverse events in older patients with advanced cancer.; JNCI cancer spectrum. 2026 Aug 24.
- Dyadic experience of uncertainty among couples following a gynecological cancer diagnosis.; Journal of health psychology. 2026 Jun 16.
- A systematic review and meta-analysis of interventions addressing sexual and gender minority stress.; Clinical psychology review; Vol 128, pp. 102779. 2026 Jun 15.
- Prevalence and correlates of current smoking among deaf, deafblind, and hard of hearing individuals.; American journal of preventive medicine. 2026 May 31.
Contact Us
HERO Lab
SRB 2.216